Recombinant Activated Factor VII (rFVIIa/ NovoSeven®) in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemorrhage; Thrombocytopenia
- Focus Therapeutic Use
- 09 Oct 2018 Status changed from recruiting to completed.
- 23 Aug 2017 Status changed from not yet recruiting to recruiting.
- 23 Aug 2017 Planned initiation date changed from 17 Aug 2017 to 21 Aug 2017.